LyondellBasell Industries NV vs Nomura Holdings Inc — how do they compare? LyondellBasell Industries NV trades at $60.03 (market cap $19.49B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: Nomura Holdings Inc is the larger of the two by market cap, and LyondellBasell Industries NV pays the higher dividend (4.57%). Which is the better fit depends on your goals — on Pluang, investors hold LyondellBasell Industries NV for 87 Days and Nomura Holdings Inc for 55 Days on average.
| LYB | NMR | |
|---|---|---|
Market Cap | $19.49B | $27.55B |
Volume | 6,033,396 | 782,470 |
Sector | Basic Materials | Financials |
52-Week High | $82.38 | $10.86 |
52-Week Low | $42.28 | $6.73 |
Typical Hold Time | 87 Days | 55 Days |
Enterprise Value | $31.08B | $38.54T |
Dividend Yield | 4.57% | 3.4% |
Signals from Pluang's Aura AI — not financial advice
LyondellBasell (LYB) trades at $60.36, up 3.19% today, showing mixed technical signals with a bearish overall trend but recent earnings beats. The company faces fundamental challenges with negative net income margin (-1.13%) and ROE (-3.19%) despite revenue stabilization around $30-31B. Recent dividend declaration of $0.69 per share provides income support while institutional activity shows mixed positioning with both increases and decreases in holdings.
Outlook remains cautious with analyst consensus at $69.38 target (15% upside) but divided ratings (45% Buy/45% Hold). Key risks include cyclical chemical demand, margin pressure from Middle East supply normalization, and declining operating cash flow trends. The stock offers value through low P/S (0.62) but requires earnings recovery to justify current valuation multiples.
Nomura Holdings (NMR) trades at $9.54, up 0.1% on the day, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Recent earnings show a mix of beats and misses, while cash flow trends indicate significant financing activity. The stock is near its support level of $9, with RSI indicators suggesting potential oversold conditions. Zacks Research highlighted NMR as a strong buy for momentum and value in September 2026, citing recent price strength.
The outlook for NMR is cautiously optimistic, supported by solid profitability and valuation, but tempered by bearish technicals and inconsistent earnings performance. Key risks include high debt levels and macroeconomic sensitivity, while analyst sentiment leans hold. Upside potential exists if earnings stabilize and technical support holds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →